메뉴 건너뛰기




Volumn 12, Issue 2, 2016, Pages 156-163

Impact of introducing catheter-based renal denervation into Japan for hypertension management: Estimation of number of target patients and clinical relevance of ambulatory blood pressure reduction

Author keywords

Ambulatory blood pressure; Blood pressure; Cohort study; Prevalence; Renal denervation; Resistant hypertension

Indexed keywords

DIURETIC AGENT;

EID: 84973667572     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/1573402112666160302102841     Document Type: Article
Times cited : (13)

References (14)
  • 1
    • 84893860901 scopus 로고    scopus 로고
    • Percutaneous renaldenervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study
    • Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renaldenervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study. Lancet 2014; 383: 622-9.
    • (2014) Lancet , vol.383 , pp. 622-629
    • Krum, H.1    Schlaich, M.P.2    Sobotka, P.A.3
  • 2
    • 84871312992 scopus 로고    scopus 로고
    • Symplicity HTN-2Investigators. Renal sympathetic denervation for treatment of drug- resistant hypertension: One-year results from the Symplicity HTN-2 randomized, controlled trial
    • Esler MD, Krum H, Schlaich M, et al. Symplicity HTN-2Investigators. Renal sympathetic denervation for treatment of drug- resistant hypertension: One-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 2012; 126: 2976-82.
    • (2012) Circulation , vol.126 , pp. 2976-2982
    • Esler, M.D.1    Krum, H.2    Schlaich, M.3
  • 3
    • 84880015206 scopus 로고    scopus 로고
    • ESH/ESCGuidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    • Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESCGuidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-357.
    • (2013) J Hypertens , vol.31 , pp. 1281-1357
    • Mancia, G.1    Fagard, R.2    Narkiewicz, K.3
  • 4
    • 84898731305 scopus 로고    scopus 로고
    • SYMPLICITY HTN-3Investigators. A controlled trial of renal denervation for resistant hypertension
    • Bhatt DL, Kandzari DE, O'Neill WW, et al. SYMPLICITY HTN-3Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-401.
    • (2014) N Engl J Med , vol.370 , pp. 1393-1401
    • Bhatt, D.L.1    Kandzari, D.E.2    O'neill, W.W.3
  • 5
    • 84991373055 scopus 로고    scopus 로고
    • SYMPLICITY HTN-JapanInvestigators. SYMPLICITY HTN-Japan: First randomized controlled trial of catheter-based renal denervation in Asian patients
    • Kario K, Ogawa H, Okumura K, et al. SYMPLICITY HTN-JapanInvestigators. SYMPLICITY HTN-Japan: First randomized controlled trial of catheter-based renal denervation in Asian patients. Circ J 2015; 79: 1222-9.
    • (2015) Circ J , vol.79 , pp. 1222-1229
    • Kario, K.1    Ogawa, H.2    Okumura, K.3
  • 6
    • 84924426046 scopus 로고    scopus 로고
    • Predictors of blood pressureresponse in the SYMPLICITY HTN-3 trial
    • Kandzari DE, Bhatt DL, Brar S, et al. Predictors of blood pressureresponse in the SYMPLICITY HTN-3 trial. Eur Heart J 2015; 36: 219-27.
    • (2015) Eur Heart J , vol.36 , pp. 219-227
    • Kandzari, D.E.1    Bhatt, D.L.2    Brar, S.3
  • 7
    • 84929606094 scopus 로고    scopus 로고
    • Renal Denervation forHypertension (DENERHTN) investigators. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): A multicentre, open-label, randomised controlled trial
    • Azizi M, Sapoval M, Gosse P, et al. Renal Denervation forHypertension (DENERHTN) investigators. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): A multicentre, open-label, randomised controlled trial. Lancet 2015; 385: 1957-65.
    • (2015) Lancet , vol.385 , pp. 1957-1965
    • Azizi, M.1    Sapoval, M.2    Gosse, P.3
  • 8
    • 84952870245 scopus 로고    scopus 로고
    • The SPYRAL HTN GlobalClinical Trial Program: Rationale and Design for studies of Renal Denervation in the Absence (SPYRAL HTN OFF-MED) and Presence (SPYRAL HTN ON-MED) of Antihypertensive Medications
    • Kandzari D, Kario K, Mahfoud F, et al. The SPYRAL HTN GlobalClinical Trial Program: Rationale and Design for studies of Renal Denervation in the Absence (SPYRAL HTN OFF-MED) and Presence (SPYRAL HTN ON-MED) of Antihypertensive Medications. Am Heart J 2016; 171: 82-91.
    • (2016) Am Heart J , vol.171 , pp. 82-91
    • Kandzari, D.1    Kario, K.2    Mahfoud, F.3
  • 9
    • 0034968899 scopus 로고    scopus 로고
    • PickeringTG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension
    • Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, PickeringTG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001; 38: 238-45.
    • (2001) J am Coll Cardiol , vol.38 , pp. 238-245
    • Kario, K.1    Shimada, K.2    Schwartz, J.E.3    Matsuo, T.4    Hoshide, S.5
  • 10
    • 0037453061 scopus 로고    scopus 로고
    • Morning surge in bloodpressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study
    • Kario K, Pickering TG, Umeda Y, et al. Morning surge in bloodpressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 2003; 107: 1401-6.
    • (2003) Circulation , vol.107 , pp. 1401-1406
    • Kario, K.1    Pickering, T.G.2    Umeda, Y.3
  • 11
    • 84898739822 scopus 로고    scopus 로고
    • Japanese Society ofHypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
    • Shimamoto K, Ando K, Fujita T, et al. Japanese Society ofHypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014; 37: 253-390.
    • (2014) Hypertens Res , vol.37 , pp. 253-390
    • Shimamoto, K.1    O, K.2    Fujita, T.3
  • 12
    • 84878946176 scopus 로고    scopus 로고
    • Proposal of a new strategy for ambulatory blood pressureprofile-based management of resistant hypertension in the era of renal denervation
    • Kario K. Proposal of a new strategy for ambulatory blood pressureprofile-based management of resistant hypertension in the era of renal denervation. Hypertens Res 2013; 36(6): 478-84.
    • (2013) Hypertens Res , vol.36 , Issue.6 , pp. 478-484
    • Kario, K.1
  • 13
    • 85186839121 scopus 로고    scopus 로고
    • Essential Manual of 24-hour Blood Pressure Managementfrom Morning to Nocturnal Hypertension, Wiley-Blackwell
    • Kario K. Essential Manual of 24-hour Blood Pressure Managementfrom Morning to Nocturnal Hypertension, Wiley-Blackwell, London, 1-138, 2015.
    • (2015) London , pp. 1-138
    • Kario, K.1
  • 14
    • 84947492194 scopus 로고    scopus 로고
    • Effect ofcatheter-based renal denervation on morning and nocturnal blood pressure. Insights from SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan
    • Kario K, Bhatt DL, Brar S, Cohen SA, Fahy M, Bakris GL. Effect ofcatheter-based renal denervation on morning and nocturnal blood pressure. Insights from SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Hypertension 2015; 66: 1130-7.
    • (2015) Hypertension , vol.66 , pp. 1130-1137
    • Kario, K.1    Bhatt, D.L.2    Brar, S.3    Cohen, S.A.4    Fahy, M.5    Bakris, G.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.